![]() ElectroCore ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders. | ![]() ReShape Lifesciences ReShape Lifesciences, a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. | ||||
Founding Date | Founding Date 2005 | Founding Date 2002 | Founding Date 2002 | Founding Date N/A | Founding Date 2011 |
Type | Type Public | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Rockaway, US HQ Parksville, CA Geretsried, DE Hamburg, DE Yeadon, GB Bernards, US | Locations San Carlos, US HQ | Locations San Clemente, US HQ San Clemente, US | Locations Dublin, IE HQ Dublin, IE | Locations Bainbridge Island, US HQ |
Employees | Employees 5144% decrease | Employees 2713% increase | Employees 4348% decrease | Employees 838% increase | Employees 31 |
Valuation ($) | Valuation ($) 71.2 m | Valuation ($) 8.5 m | Valuation ($) 3 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $32m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $11.3m (FY, 2020) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods $4.2m (FY, 2025) | Cost of goods N/A | Cost of goods $5m (FY, 2020) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $27.8m (FY, 2025) | Gross profit N/A | Gross profit $6.3m (FY, 2020) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($14m) (FY, 2025) | Net income ($8.2m) (FY, 2025) | Net income ($21.6m) (FY, 2020) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 127m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 7.5m | Total funding raised N/A |

BioCardia is a clinical-stage regenerative medicine company.
View company
ReShape Lifesciences, a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders.
View company
FIRE1 focuses on developing novel remote monitoring devices.
View company
SOLIUS (also known as Benesol) is a company that develops medical light therapy solutions.
View company